University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Trends in systemic glucocorticoid utilization in the United Kingdom from 1990 to 2019 : a population-based, serial cross-sectional analysis

dc.contributor.authorMenzies-Gow, Andrew
dc.contributor.authorTran, Trung N
dc.contributor.authorStanley, Brooklyn
dc.contributor.authorCarter, Victoria Ann
dc.contributor.authorSmolen, Josef S
dc.contributor.authorBourdin, Arnaud
dc.contributor.authorFitzGerald, J. Mark
dc.contributor.authorRaine, Tim
dc.contributor.authorChapaneri, Jatin
dc.contributor.authorEmmanuel, Benjamin
dc.contributor.authorJackson, David J
dc.contributor.authorPrice, David
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.date.accessioned2024-03-18T11:18:01Z
dc.date.available2024-03-18T11:18:01Z
dc.date.issued2024-03-15
dc.descriptionAcknowledgments The authors thank the members of the Forum for reducing Oral Corticosteroid Use in Severe asthma (FOCUS) for their involvement in the conception of the study (Table S5). Medical writing support, including preparation of the draft manuscript under the direction and guidance of the authors, incorporating author feedback, and manuscript submission, was provided by Lea Anne Gardner, PhD, RN (CiTRUS Health Group), in accordance with Good Publication Practice 2022 (GPP 2022) guidelines. This support was funded by AstraZeneca (Cambridge, UK). Data from OPCRD were obtained under license from Optimum Patient Care Limited. The interpretation and conclusions contained in this report are those of the authors alone. Funding This work was funded by AstraZeneca. In collaboration with the steering committee, AstraZeneca was involved in the study design; in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the article for publication. All authors had full access to the data, agreed to be accountable for the accuracy and integrity of the work, and shared responsibility for the decision to submit the article for publication. Steering committee members were not compensated for their participation.en
dc.description.statusPeer revieweden
dc.format.extent12
dc.format.extent1594951
dc.identifier284513734
dc.identifier7f7f9bbc-2215-4276-81f8-3fb478d67772
dc.identifier.citationMenzies-Gow, A, Tran, T N, Stanley, B, Carter, V A, Smolen, J S, Bourdin, A, FitzGerald, J M, Raine, T, Chapaneri, J, Emmanuel, B, Jackson, D J & Price, D 2024, 'Trends in systemic glucocorticoid utilization in the United Kingdom from 1990 to 2019 : a population-based, serial cross-sectional analysis', Pragmatic and Observational Research, vol. 2024, no. 15, pp. 53-64. https://doi.org/10.2147/POR.S442959en
dc.identifier.doi10.2147/POR.S442959
dc.identifier.iss15en
dc.identifier.issn1179-7266
dc.identifier.urihttps://hdl.handle.net/2164/23046
dc.language.isoeng
dc.relation.ispartofPragmatic and Observational Researchen
dc.subjectGlucocorticoidsen
dc.subjectPractice Patternsen
dc.subjectDrug prescriptionsen
dc.subjectBiological productsen
dc.subjectDrug utilizationen
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleTrends in systemic glucocorticoid utilization in the United Kingdom from 1990 to 2019 : a population-based, serial cross-sectional analysisen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Menzies_etal_POR_Trends_In_Systemic_VoR.pdf
Size:
1.52 MB
Format:
Adobe Portable Document Format

Collections